Mylotarg 4.5 MG vials
Ended Awarded
- Contract number
- SPE2DR26F9BU6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,270
Award facts
- Contract value 100% obligated
- $14,269.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,269.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for MYLOTARG 4.5 mg vials on November 17, 2025, with an ultimate completion date of December 9, 2025. This non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies an extensive portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare systems. MYLOTARG is a specialty oncology medication used in cancer treatment, consistent with AmerisourceBergen's demonstrated capability to deliver specialized pharmaceuticals and brand-name drugs across multiple therapeutic domains. The competitively awarded delivery order reflects the company's established ability to meet federal procurement requirements and support Defense Health Agency operations and other government healthcare systems through the DLA's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26F9BU6?
SPE2DR26F9BU6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26F9BU6 worth?
The government has obligated $14,270 on SPE2DR26F9BU6.
Is contract SPE2DR26F9BU6 an order under another contract?
Yes. SPE2DR26F9BU6 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9BU6 competed?
The extent of competition for SPE2DR26F9BU6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award